Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. Founded in 2007, Quanterix is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures.
Current Team (8)Update
Senior Director, Sales & Marketing
President & CEO & Board Director
Senior Director, Manufacturing Operations
CTO & VP, Research
VP, Product Development
Scientific Founder & Board Director
Funding Rounds (5) - $44MUpdate
Board Members and Advisors (6)Update
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Venture capital firm
In-Q-Tel identifies and partners with companies developing cutting-edge technologies to help...
One Kendall Square
Cambridge, MA 02139